Skip to main content
. 2022 Sep 8;35(4):e00233-21. doi: 10.1128/cmr.00233-21

TABLE 6.

Antifungal compounds available for the treatment of paracoccidioidomycosisd

Antifungal compound Formulation Total daily dose Interval between doses Route of administration Method of drug intake (empty or full stomach)
Azole compounds
 Ketoconazole Tablet 400 mg q24h Oral Empty
Solutionc 5–8 mg/kg q24h Oral Empty
 Itraconazole Capsule 200 mg q24h Oral Full
Capsule 200 mg q12h Oral Full
 Fluconazole Tablet 400 mg q12h Oral Without regard to meals
Glass bottle 400 mg q12h Intravenous
 Voriconazolea Tablet 400 mg q12h Oral 1 h before or 1 h after a meal
Glass bottle 400 mg q12h Intravenous
Amphotericin B
 AmB-db Glass bottle 50 mg q48h Intravenous
 ABLC Glass bottle 3.5 mg/kg q24h Intravenous
TMP-SMX combination Tablet 480–2,400 mg q12h Oral Without regard to meals
Suspensionc 16–20 mg/kg TMP q12h Oral Without regard to meals
Glass bottle 480–2,400 mg q12h Intravenous
a

Four hundred milligrams twice on the first day is usually given as a loading dose.

b

AmB-d (amphotericin B deoxycholate) should be used at increasing doses up to 1.0 mg/kg of body weight, not exceeding 50 mg/dose.

c

Dosage for children.

d

ABLC, amphotericin B lipid complex; TMP-SMX, trimethoprim-sulfamethoxazole, also called co-trimoxazole; q24h, every 24 h.